Question
Is PEA (palmitoylethanolamide) legit?
In context of PEA (palmitoylethanolamide)·Insufficient evidence56/100
In our editorial model, PEA (palmitoylethanolamide) maps to a Insufficient evidence verdict at 56/100 overall (evidence 48/100, safety 72/100, hype gap 64/100). Neuropathic pain niche trials; Anti-inflammatory marketing. Typical label framing: Studies often hundreds of mg/day micronized formulations.
Full ingredient file
This page is a short answer. Mechanisms, dosing notes, sources, and the rest of the verdict live on the hub for PEA (palmitoylethanolamide).
Open PEA (palmitoylethanolamide) verdictOther questions on PEA (palmitoylethanolamide)
A few more focused pages for the same ingredient (we keep lists short on purpose).